Targeted Inhibition of Cardiomyocyte Gi Signaling Enhances Susceptibility to Apoptotic Cell Death in Response to Ischemic Stress
Author(s) -
Brent R. DeGeorge,
Erhe Gao,
Matthieu Boucher,
Leif Erik Vinge,
Jeffrey S. Martini,
Philip Raake,
J. Kurt Chuprun,
David M. Harris,
Gilbert W. Kim,
Stephen Soltys,
Andrea D. Eckhart,
Walter J. Koch
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.752618
Subject(s) - downregulation and upregulation , in vivo , medicine , apoptosis , signal transduction , adenylyl cyclase , g alpha subunit , gs alpha subunit , g protein , microbiology and biotechnology , knockout mouse , ischemia , genetically modified mouse , endocrinology , receptor , pharmacology , transgene , biology , protein subunit , biochemistry , gene
A salient characteristic of dysfunctional myocardium progressing to heart failure is an upregulation of the adenylyl cyclase inhibitory guanine nucleotide (G) protein alpha subunit, G alpha(i2). It has not been determined conclusively whether increased Gi activity in the heart is beneficial or deleterious in vivo. Gi signaling has been implicated in the mechanism of cardioprotective agents; however, no in vivo evidence exists that any of the G alpha subunits are cardioprotective. We have created a novel molecular tool to specifically address the role of Gi proteins in normal and dysfunctional myocardium.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom